Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment.

Source:http://linkedlifedata.com/resource/pubmed/id/14537119

Download in:

View as

General Info

PMID
14537119